Piroxicam-β-Cyclodextrin in the Treatment of Headache

G. Nappi, G. C. Manzoni, C. Oliani

Research output: Contribution to journalArticle

Abstract

Piroxicam-β-cyclodextrin has been shown to give pain relief comparable to that with indomethacin and significantly greater than that with naproxen and piroxicam alone in the treatment of primary and migraine headaches. In addition, it would appear to be of use in the prophylaxis of migraine headaches, although further studies are required. The incidence of side effects with piroxicam-β-cyclodextrin was substantially less than that with comparable drugs, particularly with regard to gastrointestinal side effects. In view of its efficacy, tolerability and apparent prophylactic properties, piroxicam-β-cyclodextrin would appear to be a useful analgesic in the treatment of primary or migraine headaches.

Original languageEnglish
Pages (from-to)79-85
Number of pages7
JournalDrug Investigation
Volume2
Issue number4
DOIs
Publication statusPublished - 1990

Fingerprint

Piroxicam
Cyclodextrins
Headache
Migraine Disorders
Naproxen
Therapeutics
Indomethacin
Analgesics
Pain
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Piroxicam-β-Cyclodextrin in the Treatment of Headache. / Nappi, G.; Manzoni, G. C.; Oliani, C.

In: Drug Investigation, Vol. 2, No. 4, 1990, p. 79-85.

Research output: Contribution to journalArticle

Nappi, G, Manzoni, GC & Oliani, C 1990, 'Piroxicam-β-Cyclodextrin in the Treatment of Headache', Drug Investigation, vol. 2, no. 4, pp. 79-85. https://doi.org/10.1007/BF03258232
Nappi, G. ; Manzoni, G. C. ; Oliani, C. / Piroxicam-β-Cyclodextrin in the Treatment of Headache. In: Drug Investigation. 1990 ; Vol. 2, No. 4. pp. 79-85.
@article{0d664705bb6146bead810841de56b305,
title = "Piroxicam-β-Cyclodextrin in the Treatment of Headache",
abstract = "Piroxicam-β-cyclodextrin has been shown to give pain relief comparable to that with indomethacin and significantly greater than that with naproxen and piroxicam alone in the treatment of primary and migraine headaches. In addition, it would appear to be of use in the prophylaxis of migraine headaches, although further studies are required. The incidence of side effects with piroxicam-β-cyclodextrin was substantially less than that with comparable drugs, particularly with regard to gastrointestinal side effects. In view of its efficacy, tolerability and apparent prophylactic properties, piroxicam-β-cyclodextrin would appear to be a useful analgesic in the treatment of primary or migraine headaches.",
author = "G. Nappi and Manzoni, {G. C.} and C. Oliani",
year = "1990",
doi = "10.1007/BF03258232",
language = "English",
volume = "2",
pages = "79--85",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis Press",
number = "4",

}

TY - JOUR

T1 - Piroxicam-β-Cyclodextrin in the Treatment of Headache

AU - Nappi, G.

AU - Manzoni, G. C.

AU - Oliani, C.

PY - 1990

Y1 - 1990

N2 - Piroxicam-β-cyclodextrin has been shown to give pain relief comparable to that with indomethacin and significantly greater than that with naproxen and piroxicam alone in the treatment of primary and migraine headaches. In addition, it would appear to be of use in the prophylaxis of migraine headaches, although further studies are required. The incidence of side effects with piroxicam-β-cyclodextrin was substantially less than that with comparable drugs, particularly with regard to gastrointestinal side effects. In view of its efficacy, tolerability and apparent prophylactic properties, piroxicam-β-cyclodextrin would appear to be a useful analgesic in the treatment of primary or migraine headaches.

AB - Piroxicam-β-cyclodextrin has been shown to give pain relief comparable to that with indomethacin and significantly greater than that with naproxen and piroxicam alone in the treatment of primary and migraine headaches. In addition, it would appear to be of use in the prophylaxis of migraine headaches, although further studies are required. The incidence of side effects with piroxicam-β-cyclodextrin was substantially less than that with comparable drugs, particularly with regard to gastrointestinal side effects. In view of its efficacy, tolerability and apparent prophylactic properties, piroxicam-β-cyclodextrin would appear to be a useful analgesic in the treatment of primary or migraine headaches.

UR - http://www.scopus.com/inward/record.url?scp=0025676334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025676334&partnerID=8YFLogxK

U2 - 10.1007/BF03258232

DO - 10.1007/BF03258232

M3 - Article

AN - SCOPUS:0025676334

VL - 2

SP - 79

EP - 85

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 4

ER -